TNGX: Tango Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,173.90
Enterprise Value ($M) 1,115.37
Book Value ($M) 276.60
Book Value / Share 2.71
Price / Book 4.24
NCAV ($M) 219.30
NCAV / Share 2.15
Price / NCAV 5.35

Profitability (mra)
Return on Invested Capital (ROIC) -0.32
Return on Assets (ROA) -0.23
Return on Equity (ROE) -0.40

Liquidity (mrq)
Quick Ratio 8.54
Current Ratio 8.54

Balance Sheet (mrq) ($M)
Current Assets 370.89
Assets 428.19
Liabilities 151.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Southpoint Capital Advisors LP 5.20 17.26
02-13 13G/A Gilead Sciences Inc 4.80 0.00
02-09 13G/A Fmr Llc 9.60 -27.76
10-18 13D/A BCTG Holdings, LLC 15.00 7.60
10-16 13G/A EcoR1 Capital, LLC 13.10 70.30
08-21 13G Nextech Crossover I GP S.a r.l. 5.40
2023-02-14 13G/A Casdin Capital, LLC 0.00 -100.00
2023-02-14 13G/A Cormorant Asset Management, LP 4.67 -15.97

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-02-23 43,077 383,592 11.23
2024-02-22 47,827 487,691 9.81
2024-02-21 170,007 644,079 26.40
2024-02-20 189,244 1,115,307 16.97

(click for more detail)

Similar Companies
TENK – TenX Keane Acquisition TKNO – Alpha Teknova, Inc.
TLPH – Talphera, Inc. TRDA – Entrada Therapeutics, Inc.
TRVI – Trevi Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io